Vildagliptin (LAF-237)是一种高效稳定的选择性二肽基肽酶-IV抑制剂，具有优异的口服生物利用度与降血糖活性。
| 英文别名 (English Synonym) | Vildagliptin (LAF-237) |
| 中文名称 (Chinese Name) | 维格列汀 |
| 靶点 (Target) | DPP-4 |
| 通路 (Pathway) | Protease/Metabolic Enzyme |
| CAS号 (CAS NO.) | 274901-16-5 |
| 分子式 (Formula) | C17H25N3O2 |
| 分子量 (Molecular Weight) | 303.4 |
| 纯度 (Purity) | ≥98% |
| 溶解性 (Solubility) | 溶于DMSO |
-25~-15℃保存，有效期3年
[1] Wu YJ, Guo X, Li CJ, Li DQ, Zhang J, Yang Y, Kong Y, Guo H, Liu DM, Chen LM. Dipeptidyl peptidase-4 inhibitor, vildagliptin, inhibits pancreatic beta cell apoptosis in association with its effects suppressing endoplasmic reticulum stress in db/db mice. Metabolism. 2015 Feb;64(2):226-35. doi: 10.1016/j.metabol.2014.08.006. Epub 2014 Aug 15. PMID: 25195070.
[2] Villhauer EB, Brinkman JA, Naderi GB, Burkey BF, Dunning BE, Prasad K, Mangold BL, Russell ME, Hughes TE. 1-[[(3-hydroxy-1-adamantyl)amino]acetyl]-2-cyano-(S)-pyrrolidine: a potent, selective, and orally bioavailable dipeptidyl peptidase IV inhibitor with antihyperglycemic properties. J Med Chem. 2003 Jun 19;46(13):2774-89. doi: 10.1021/jm030091l. PMID: 12801240.
